Ticker LaunchRegulation A · Tier 2
Fisher Wallace Laboratories, Inc.
Fisher Wallace Laboratories, Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on Jan 17, 2023 for up to $10M at $10.67 per security. The SEC qualified the offering on Feb 24, 2023. Underwriter or broker: S, t and a.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $10M
- Offer price
- $10.67
- Security type
- Equity (common or preferred stock)
- Filed
- Jan 17, 2023
- Qualified
- Feb 24, 2023
- Industry
- Surgical & Medical Instruments & Apparatus
- State
- NY
- Underwriter / broker
- S, t, a, r, E, n, g, i, e, P, m, y, L and C
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Jan 17, 2023
- Final offering circular (253G2)
- All filings on EDGAR CIK 1787792
Other qualified Healthcare Reg A offerings
- Monogram Technologies Inc.Mar 1, 2023 · $30M
- Iremedy Healthcare Companies, Inc.Feb 13, 2023 · $28.8M
- Dimicron Inc.Jan 24, 2023 · $15.8M
- ETHEMA HEALTH CorpNov 18, 2022 · $5M
- DNALabs Canada Inc.Oct 21, 2022 · $1000K
- McGinley Orthopaedic Innovations, Inc.Sep 13, 2022 · $40M